GO
Loading...

Eli Lilly CEO: Hope to publish migraine data late 2014

Monday, 13 Jan 2014 | 1:30 PM ET

Eli Lilly Chairman & CEO John Lechleiter provides insight on its rights to an experimental migraine drug.